Serum adiponectin as a biomarker for chronic obstructive pulmonary disease and lung cancer and its relation to severity

[1] Barues PJ(2009)Systemic manifestations and comorbidities of COPD Eur Respir J 33 1165-1185

[2] Celli BR(2012)Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am J Respir Critcare Med 185 44-52

[3] Nishimura M(2013)Club cell protein 15 and disease progression in COPD Am J Respir Crit Care Med 188 1413-1419

[4] Makita H(2013)Retrospective analysis of the relationship between decline in FEV1 and abdominal circumference in male smokers:The Takahata study Int J Med SCi 10 1-7

[5] Nagaik K(2004)Adiponectin and metabolic syndrome Anterioxler Thromb Vasc Biol 24 29-33

[6] Nasuhara Y(2007)Fulcuo KaA:elevated circulating plasma adiponectin inunderweight pts. withCOPD Chest 132 135-140

[7] Hasegawa M(2011)Physical activity is the strongest predictor of all-cause mortality in patients with COPD:a prospective Cohort study Chest 140 331-342

[8] Shimizu K(2012)The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin Chest 142 893-899

[9] Park HY(2004)Endocrine regulation of energy metabolism:review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin and resist in Clin Chem 50 1511-1525

[10] Churg A(2005)Systemic inflammation, cachexia and prognosis in patients with cancer Curr Opin Clin Nutr Metab Care 8 265-269

[1] Barues PJ(2009)Systemic manifestations and comorbidities of COPD Eur Respir J 33 1165-1185

[2] Celli BR(2012)Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am J Respir Critcare Med 185 44-52

[3] Nishimura M(2013)Club cell protein 15 and disease progression in COPD Am J Respir Crit Care Med 188 1413-1419

[4] Makita H(2013)Retrospective analysis of the relationship between decline in FEV1 and abdominal circumference in male smokers:The Takahata study Int J Med SCi 10 1-7

[5] Nagaik K(2004)Adiponectin and metabolic syndrome Anterioxler Thromb Vasc Biol 24 29-33

[6] Nasuhara Y(2007)Fulcuo KaA:elevated circulating plasma adiponectin inunderweight pts. withCOPD Chest 132 135-140

[7] Hasegawa M(2011)Physical activity is the strongest predictor of all-cause mortality in patients with COPD:a prospective Cohort study Chest 140 331-342

[8] Shimizu K(2012)The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin Chest 142 893-899

[9] Park HY(2004)Endocrine regulation of energy metabolism:review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin and resist in Clin Chem 50 1511-1525

[10] Churg A(2005)Systemic inflammation, cachexia and prognosis in patients with cancer Curr Opin Clin Nutr Metab Care 8 265-269